Halláscsökkenés és fülzúgás vizsgálata 2-es típusú cukorbetegekben

Translated title of the contribution: Hearing impairment and tinnitus in patients with type 2 diabetes

A. Somogyi, Klára Rosta, Tibor Vaszi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Introduction: Hearing impairment is one of the most frequent chronic health issue. The incidence of hearing impairment and tinnitus increases with age. Aim: The aim of the authors was to determine the prevalence of hearing impairment and tinnitus in type 2 diabetic patients and to examine the possible associations between hearing impairment and/or tinnitus and increased HbA 1c levels. Methods: 103 patients with type 2 diabetes (47 men, 56 women; age, 61.6±10.3 years, mean±SD; range, 33-88 years) evaluated at the 2nd Department of Medicine, Semmelweis University were enrolled in this study and the results were compared to those obtained from 589 type 2 diabetic (253 men, 336 women; age, 55.4±11.0 years, mean±SD; range, 26-97 years) and 15 622 non-diabetic patients (7002 men, 8620 women; age, 55.1±11.1 years, mean±SD; range, 26-98 years) who participated in a comprehensive health screening programme in Hungary. Hearing impairment was determined using the Interacoustics model AS608 screening audiometer in all patient groups. Tinnitus was evaluated with questionnaire. Results: It was found that hearing impairment and/or tinnitus occurred in a very high proportion of type 2 diabetic patients evaluated at the 2nd Department of Medicine, Semmelweis University (80% of cases) as compared to type 2 diabetic (34% of cases) and non-diabetic patients (14% of cases) enrolled in the national health screening programme. There was no significant correlation between increased HbA 1c levels and hearing impairment or tinnitus in type 2 diabetic patients. Conclusion: These results suggest that the prevalence of hearing impairment and tinnitus is higher and develop at an earlier age in patients with type 2 diabetes. The results indicate a high prevalence of hearing impairment and tinnitus in type 2 diabetic patients.

Original languageHungarian
Pages (from-to)363-368
Number of pages6
JournalOrvosi Hetilap
Volume154
Issue number10
DOIs
Publication statusPublished - Mar 1 2013

Fingerprint

Tinnitus
Hearing Loss
Type 2 Diabetes Mellitus
Medicine
Hungary
Health
National Health Programs
Incidence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Halláscsökkenés és fülzúgás vizsgálata 2-es típusú cukorbetegekben. / Somogyi, A.; Rosta, Klára; Vaszi, Tibor.

In: Orvosi Hetilap, Vol. 154, No. 10, 01.03.2013, p. 363-368.

Research output: Contribution to journalArticle

Somogyi, A. ; Rosta, Klára ; Vaszi, Tibor. / Halláscsökkenés és fülzúgás vizsgálata 2-es típusú cukorbetegekben. In: Orvosi Hetilap. 2013 ; Vol. 154, No. 10. pp. 363-368.
@article{ae803c7c91d140519aaa4a7a846e0ce7,
title = "Hall{\'a}scs{\"o}kken{\'e}s {\'e}s f{\"u}lz{\'u}g{\'a}s vizsg{\'a}lata 2-es t{\'i}pus{\'u} cukorbetegekben",
abstract = "Introduction: Hearing impairment is one of the most frequent chronic health issue. The incidence of hearing impairment and tinnitus increases with age. Aim: The aim of the authors was to determine the prevalence of hearing impairment and tinnitus in type 2 diabetic patients and to examine the possible associations between hearing impairment and/or tinnitus and increased HbA 1c levels. Methods: 103 patients with type 2 diabetes (47 men, 56 women; age, 61.6±10.3 years, mean±SD; range, 33-88 years) evaluated at the 2nd Department of Medicine, Semmelweis University were enrolled in this study and the results were compared to those obtained from 589 type 2 diabetic (253 men, 336 women; age, 55.4±11.0 years, mean±SD; range, 26-97 years) and 15 622 non-diabetic patients (7002 men, 8620 women; age, 55.1±11.1 years, mean±SD; range, 26-98 years) who participated in a comprehensive health screening programme in Hungary. Hearing impairment was determined using the Interacoustics model AS608 screening audiometer in all patient groups. Tinnitus was evaluated with questionnaire. Results: It was found that hearing impairment and/or tinnitus occurred in a very high proportion of type 2 diabetic patients evaluated at the 2nd Department of Medicine, Semmelweis University (80{\%} of cases) as compared to type 2 diabetic (34{\%} of cases) and non-diabetic patients (14{\%} of cases) enrolled in the national health screening programme. There was no significant correlation between increased HbA 1c levels and hearing impairment or tinnitus in type 2 diabetic patients. Conclusion: These results suggest that the prevalence of hearing impairment and tinnitus is higher and develop at an earlier age in patients with type 2 diabetes. The results indicate a high prevalence of hearing impairment and tinnitus in type 2 diabetic patients.",
keywords = "hearing impairment, tinnitus, type 2 diabetes mellitus",
author = "A. Somogyi and Kl{\'a}ra Rosta and Tibor Vaszi",
year = "2013",
month = "3",
day = "1",
doi = "10.1556/OH.2013.29562",
language = "Hungarian",
volume = "154",
pages = "363--368",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "10",

}

TY - JOUR

T1 - Halláscsökkenés és fülzúgás vizsgálata 2-es típusú cukorbetegekben

AU - Somogyi, A.

AU - Rosta, Klára

AU - Vaszi, Tibor

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Introduction: Hearing impairment is one of the most frequent chronic health issue. The incidence of hearing impairment and tinnitus increases with age. Aim: The aim of the authors was to determine the prevalence of hearing impairment and tinnitus in type 2 diabetic patients and to examine the possible associations between hearing impairment and/or tinnitus and increased HbA 1c levels. Methods: 103 patients with type 2 diabetes (47 men, 56 women; age, 61.6±10.3 years, mean±SD; range, 33-88 years) evaluated at the 2nd Department of Medicine, Semmelweis University were enrolled in this study and the results were compared to those obtained from 589 type 2 diabetic (253 men, 336 women; age, 55.4±11.0 years, mean±SD; range, 26-97 years) and 15 622 non-diabetic patients (7002 men, 8620 women; age, 55.1±11.1 years, mean±SD; range, 26-98 years) who participated in a comprehensive health screening programme in Hungary. Hearing impairment was determined using the Interacoustics model AS608 screening audiometer in all patient groups. Tinnitus was evaluated with questionnaire. Results: It was found that hearing impairment and/or tinnitus occurred in a very high proportion of type 2 diabetic patients evaluated at the 2nd Department of Medicine, Semmelweis University (80% of cases) as compared to type 2 diabetic (34% of cases) and non-diabetic patients (14% of cases) enrolled in the national health screening programme. There was no significant correlation between increased HbA 1c levels and hearing impairment or tinnitus in type 2 diabetic patients. Conclusion: These results suggest that the prevalence of hearing impairment and tinnitus is higher and develop at an earlier age in patients with type 2 diabetes. The results indicate a high prevalence of hearing impairment and tinnitus in type 2 diabetic patients.

AB - Introduction: Hearing impairment is one of the most frequent chronic health issue. The incidence of hearing impairment and tinnitus increases with age. Aim: The aim of the authors was to determine the prevalence of hearing impairment and tinnitus in type 2 diabetic patients and to examine the possible associations between hearing impairment and/or tinnitus and increased HbA 1c levels. Methods: 103 patients with type 2 diabetes (47 men, 56 women; age, 61.6±10.3 years, mean±SD; range, 33-88 years) evaluated at the 2nd Department of Medicine, Semmelweis University were enrolled in this study and the results were compared to those obtained from 589 type 2 diabetic (253 men, 336 women; age, 55.4±11.0 years, mean±SD; range, 26-97 years) and 15 622 non-diabetic patients (7002 men, 8620 women; age, 55.1±11.1 years, mean±SD; range, 26-98 years) who participated in a comprehensive health screening programme in Hungary. Hearing impairment was determined using the Interacoustics model AS608 screening audiometer in all patient groups. Tinnitus was evaluated with questionnaire. Results: It was found that hearing impairment and/or tinnitus occurred in a very high proportion of type 2 diabetic patients evaluated at the 2nd Department of Medicine, Semmelweis University (80% of cases) as compared to type 2 diabetic (34% of cases) and non-diabetic patients (14% of cases) enrolled in the national health screening programme. There was no significant correlation between increased HbA 1c levels and hearing impairment or tinnitus in type 2 diabetic patients. Conclusion: These results suggest that the prevalence of hearing impairment and tinnitus is higher and develop at an earlier age in patients with type 2 diabetes. The results indicate a high prevalence of hearing impairment and tinnitus in type 2 diabetic patients.

KW - hearing impairment

KW - tinnitus

KW - type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=84874778108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874778108&partnerID=8YFLogxK

U2 - 10.1556/OH.2013.29562

DO - 10.1556/OH.2013.29562

M3 - Article

C2 - 23461976

AN - SCOPUS:84874778108

VL - 154

SP - 363

EP - 368

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 10

ER -